NCT01154790View on ClinicalTrials.gov

Phase I Study on Multiple Oral Dosing of CG100649

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Healthy
Interventions
DRUG

CG100649

6 subjects: study drug 2 subjects: placebo

DRUG

Placebo

6 subjects: study drug 2 subjects: placebo

DRUG

Naproxen

6 subjects: study drug 2 subjects: placebo

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

CrystalGenomics, Inc.

INDUSTRY